“Tumor-targeted costimulatory trimerbodies for cancer immunotherapy.”- A brief discussion with Juan Perez Villar, CEO, LeadArtis.

“Tumor-targeted costimulatory trimerbodies for cancer immunotherapy.”-  A brief discussion with Juan Perez Villar, CEO, LeadArtis.

Doctor in Immunology from the Autonomous University of Madrid (Spain), extensive international career in the biopharmaceutical industry at Astellas Inc. and Bristol-Myers Squibb Co. (USA). Experienced R&D leader in immune-oncology (IO). Previously, participated in preclinical development of CD28 biologic modulators for inflammatory conditions, small molecule tyrosine kinase inhibitors and fully human antibodies for advanced solid tumors at Leadartis. He advanced the company from start to capitalize on the immuno-oncology (IO) market. Evaluated and repositioned the platform technology to create IO bispecific antibody dominance and created a proprietary next generation product…

Read More

Héctor Pérez Montoyo, of Ability Pharma discusses his research on, “ABTL0812, a new immunotherapeutic anticancer agent at phase 2b clinical stage.”

Héctor Pérez Montoyo, of Ability Pharma discusses his research on, “ABTL0812, a new immunotherapeutic anticancer agent at phase 2b clinical stage.”

Héctor’s work has always focused on understanding the molecular pathophysiological mechanisms leading to autoimmunity and cancer development, investigating mechanism of action of newly developed molecules to treat such diseases. He started his career in 2006 when he moved to UT Southwestern Medical Center in Dallas (EEUU), to carry out this thesis in developing novel therapeutic antibodies in murine models of human autoimmune diseases. After obtaining his Ph.D., he combined two postdoctoral grants in Barcelona (Metastasis and Transformation group in Bellvitge Biomedical Research Center) and in Valencia (Autoimmune Pathology Lab in…

Read More

Dr. William Williams of Briacell Therapeutics Corporation talks about Personalized, off-the-shelf cellular immunotherapy for cancer

Dr. William Williams of  Briacell Therapeutics Corporation talks about Personalized, off-the-shelf cellular immunotherapy for cancer

Dr. Williams is the President and CEO of BriaCell Corporation, where he has shepherded Bria-IMT™ into the clinic, established positive proof-of-concept, forged a collaboration with Incyte for novel combinations and coordinated the development of an off-the-shelf personalized approach to cancer immunotherapy. While at Incyte Corporation as Head of Exploratory Development, he brought numerous molecules into the clinic and established proof of concept in several disease areas. At GlaxoSmithKline he worked to bring several molecules into the clinic, ran a biomarker laboratory and spearheaded initiatives to utilize emerging technologies in drug…

Read More

Discussing the Top 10 Opportunities in Robotics at the MarketsandMarkets Robotics CRYSTAL BALL EVENT!

Discussing the Top 10 Opportunities in Robotics at the MarketsandMarkets Robotics CRYSTAL BALL EVENT!

February 24th – MarketsandMarkets Robotics CRYSTAL BALL EVENT on the March 9, 2021 will host industry giants Softbank Robotics America, 6 River Systems, Fetch Robotics and Denso to present their thoughts on the Top 10 Opportunities in Robotics in the next 5 year!  The MarketsandMarkets Robotics CRYSTAL BALL EVENT will gather 100+ professionals from industry giants such as Innoviz Technologies, Travelport, GM Modular Pvt. Ltd, Venture Talent Solutions, Unipac, Movandi Corp, Sirius Unbound, Shindengen America, Inc., Konica Minolta Business Solutions, Raymond James, University of Waterloo, National Grid, Polyexplore, Owl Cyber Defense, Polpharma, Advantech, New Normal Digital Inc., AiGraphics, Persistent, Microchip, Amazon.com, Cabrzill Pvt Ltd, Invesco, Freepoint, Gen II Fund Services, LLC, Uchimura Robotics LLC, SpotOn, Akzonobel, Owens Design, B2Holding ASA, etc.  A host of attractive, high growth opportunities such as Smart Factory, Precision Agriculture, Last Mile Delivery, Warehouse Automation, Cooperative & Network Robotics, Entertainment Robotics,…

Read More

Discussing Top 10 Disruptions in BioPharma Manufacturing at the MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT!

Discussing Top 10 Disruptions in BioPharma Manufacturing at the MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT!

February 26th – MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT on the March 11, 2021 will hostindustry giants Fresenius Kabi, Charles River Laboratories, GenScript ProBio, Pall Corporation and MilliporeSigma to present their thoughts on the Top 10 Disruptions Through BioPharma Manufacturing in the next 5 year! MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT will gather 100+ professionals from industry giants such as Biocon Biologics, Ology Bioservices, Celonic AG, Gyroscope Therapeutics, GenIbet, Hemobras, H2i Group, MilliporeSigma, Orange Grove Bio, HORIBA, Porex Life Sciences Institute, Kaneka, Lonza, Cytiva, GEA North America, Batavia Biosciences, Nova…

Read More

Discussing Top 10 Disruptions Through Artificial Intelligence at the MarketsandMarkets Artificial Intelligence CRYSTAL BALL EVENT!

Discussing Top 10 Disruptions Through Artificial Intelligence at the MarketsandMarkets Artificial Intelligence CRYSTAL BALL EVENT!

February 26th – MarketsandMarkets Artificial Intelligence CRYSTAL BALL EVENT on the March 10, 2021 will hostindustry giants Google, IBM Global Markets, Avaya International and Intellio to present their thoughts on the Top 10 Disruptions Through Artificial Intelligence in the next 5 year! The MarketsandMarkets Artificial Intelligence CRYSTAL BALL EVENT will gather 100+ professionals from industry giants such as JUJU Solutions, Retlewski & Associates, Oracle, Harman South America, Microsoft, Arus, 3Insy,s VFS Ventures, c/o Architecture Technology Corp., ABB, Travelport, Coca-Cola European Partners, Polyexplore, RGA, Polpharma, Ricoh, SAS, vettd.ai, Advantech, Drexel, Persistent,…

Read More

Discussing “Laboratory miniaturization hand in hand with Microfabrication and Nanotechnology – systems integration at the microscale “with Dr. Vania Silverio of INESC-MN, Portugal.

Discussing “Laboratory miniaturization hand in hand with Microfabrication and Nanotechnology – systems integration at the microscale “with Dr. Vania Silverio of INESC-MN, Portugal.

Dr. Vania Silverio is a Microfluidics architect with strong background in microengineering. She combines know-how in simulation, design and fabrication of micron-sized fluidic paths with the integration of sensing and actuation elements towards the miniaturization of laboratories. Dr. Silverio is the Leader of the Microfluidics group at INESC Microsystems and Nanotechnologies (INESC MN) providing modular microfluidic solutions. She is Invited Assistant Professor at the Physics Department of Instituto Superior Tecnico (IST), ULisboa where, among others, she is the responsible for the curricular course on Microfluidics, unique in Portugal. She supervises…

Read More

Nicola Hodges from Royal United Hospitals Bath NHS Foundation, speaks about “Application of Point-Of-Care in disease outbreak”

Nicola Hodges from Royal United Hospitals Bath NHS Foundation, speaks about “Application of Point-Of-Care in disease outbreak”

Nicola is the POCT coordinator at the Royal United Hospitals Bath Foundation Trust and have been for just over 2 years now. She has been a senior biomedical scientist in biochemistry in the manual section again for around 2 years before this and a specialist BMS since 2003. Her most recent education was the certificate in expert practice in POCT awarded by the IBMS in 2021. She has always had a great passion for POCT, and she enjoys her job despite the many challenges. She believes that POCT is the…

Read More

Linda Krebs, & Allison Krebs-Bensch, of BeBe & Bella, LLC talk about V-Bella Homeopathic Boric Acid and Probiotic blend vaginal suppositories.

Linda Krebs, & Allison Krebs-Bensch, of BeBe & Bella, LLC talk about V-Bella Homeopathic Boric Acid and Probiotic blend vaginal suppositories.

Linda and Allison have had a lifelong commitment to wellbeing and overall health. Living in the sunny South, they understand that proper skincare is an essential aspect of everyday life. In 2013 they became business partners creating the groundbreaking probiotic based skin care company – BeBe & Bella, LLC. Allison Krebs-Bensch, CEO of US Pharmaceutical Corporation, CEO and Co-Founder of BeBe & Bella, LLC followed her father in his original profession as a scientific innovator. As a trailblazer, Allison is always pushing to formulate products around new scientific discoveries. It…

Read More

Discussing ‘Reducing Errors at Point-Of-Care’ with Uchenna Okeahiala of Airedale and Bradford Hospitals Integrated Pathology Solutions, UK .

Discussing ‘Reducing Errors at Point-Of-Care’ with Uchenna Okeahiala of Airedale and Bradford Hospitals Integrated Pathology Solutions, UK .

Graduated from University of Nigeria with a bachelor’s degree in Biomedical Sciences in 1989, Uchenna started her career as a Biomedical Scientist in Nigeria She relocated to the United Kingdom in 1991 where she obtained her Master’s degree in Biomedical Sciences from University of Cardiff with a Distinction in 1996 and went on to score a certificate in management from the Open University (1999). Later in 2006, she obtained a certificate in Extended Practice in Quality Management with Institute of Biomedical Sciences (IBMS). Since then has worked in various NHS…

Read More